{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:32:50Z","timestamp":1769880770585,"version":"3.49.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Science and Technology Development Fund, Macau SAR","award":["0098 \/ 2021 \/ A2"],"award-info":[{"award-number":["0098 \/ 2021 \/ A2"]}]},{"name":"the National Traditional Chinese Medicine Inheritance and Innovation Team","award":["ZYCXTD-C-202207"],"award-info":[{"award-number":["ZYCXTD-C-202207"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074378"],"award-info":[{"award-number":["82074378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Southwest Medical University Project","award":["2021ZKQN143"],"award-info":[{"award-number":["2021ZKQN143"]}]},{"name":"Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province","award":["20221354"],"award-info":[{"award-number":["20221354"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20210324111213038"],"award-info":[{"award-number":["JCYJ20210324111213038"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The incidence of heart failure (HF) is increasing year by year, posing a great threat to human health. Although pharmacotherapy has been able to significantly prolong patient survival, pharmacotherapy for HF still has limitations due to its complex pathogenesis and considerable individual variability, there is a great need to explore complementary and alternative therapies to slow down the progression of HF. Danshen decoction is used to treat several cardiovascular diseases including HF, but the efficacy of stabilization is uncertain. This meta-analysis evaluated the clinical efficacy of Danshen Decoction for the treatment of HF.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The registration number assigned to this meta-analysis on the PROSPERO platform is CRD42022351918. Four databases were searched, and randomized controlled trials (RCTs) of Danshen decoction combined with conventional treatment (CT) of HF were screened, CT included medical treatments other than Danshen Decoction to which the patient was treated (including but not limited to angiotensin converting enzyme inhibitor, angiotensin receptor blocker, angiotensin receptor neprilysin inhibitors, \u03b2-blockers, diuretics, mineralcorticoid recept antagonist etc.). The clinical efficacy rate (CER), left ventricular ejection fraction (LVEF), left ventricular end-diastolic dimension (LVEDD), left ventricular end-systolic diameter (LVESD), brain natriuretic peptide (BNP), N-terminal pro-B type natriuretic peptide (NT-proBNP) and hypersensitive C-reactive protein (hs-CRP) were included as outcome indicators. The GRADE grading scale was used to grade the above indicators. The Cochrane risk-of-bias tool and the Jadad quality scale were used to assess the methodological quality of RCTs. Finally, RevMan V.4.5 software was used for data synthesis, 95% confidence intervals (CI) for dichotomous data, risk ratios (RR), and mean differences (MD) for continuous variables were calculated, Chi-square and <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> were used for heterogeneity assessment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Nine RCTs with a total of 855 patients were included in this study, and all included RCTs had a low overall quality risk of bias and high quality of reported information. The results of the meta-analysis showed that compared with the use of CT, CER (%) was significantly improved due to Danshen decoction combined with CT (MD = 3.95, 95% CI [2.58, 6.04], <jats:italic>P<\/jats:italic> &lt; 0.00001), LVEF (%) was significantly improved (MD = 5.46, 95% CI [5.32, 5.60], <jats:italic>P<\/jats:italic> &lt; 0.00001), LVEDD (mm) was significantly reduced (MD = -5.27, 95% CI [-6.21, -4.32], <jats:italic>P<\/jats:italic> &lt; 0.00001), LVESD (mm) was significantly reduced (MD = -4.60, 95% CI [-5.87, -3.32], <jats:italic>P<\/jats:italic> &lt; 0.00001), BNP (pg\/mL) was significantly reduced (MD = -88.61, 95% CI [-121.98, -55.24], <jats:italic>P<\/jats:italic> &lt; 0.00001), NT-proBNP (pg\/mL) was significantly decreased (SMD = -3.33, 95% CI [-5.92, -0.73], <jats:italic>P<\/jats:italic> = 0.01), hs-CRP (mg\/L) was significantly decreased (MD = -2.73, 95% CI [-4.11, -1.34], <jats:italic>P<\/jats:italic> = 0.0001). The quality of the GRADE evidence for all outcomes was moderate to low and no RCTs reported adverse events.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our research demonstrates that Danshen decoction is an effective and safe treatment option for HF. Nevertheless, considering the limitations of methodological and the quality of RCTs, more rigorous, large-scale, multicenter randomized clinical trials are needed to further evaluate the efficacy and safety of Danshen decoction in the treatment of HF patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0284877","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T17:33:30Z","timestamp":1683308010000},"page":"e0284877","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1371","volume":"18","author":[{"given":"Ziyi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-642X","authenticated-orcid":true,"given":"Mengnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingtai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qibiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"pone.0284877.ref001","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"A Mosterd","year":"2007","journal-title":"Heart"},{"key":"pone.0284877.ref002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute Heart Failure: Definition, Classification and Epidemiology.","volume":"14","author":"S Kurmani","year":"2017","journal-title":"Curr Heart Fail Rep."},{"key":"pone.0284877.ref003","doi-asserted-by":"crossref","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","article-title":"Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis","volume":"14","author":"H Wang","year":"2021","journal-title":"Circ Heart Fail"},{"key":"pone.0284877.ref004","first-page":"577","article-title":"The Writing Committee of the Report on Cardiovascular Health and Diseases in China 2021. Overview of the China Cardiovascular Health and Disease Report 2021","volume":"20","year":"2022","journal-title":"Cardiovascular Research in China"},{"key":"pone.0284877.ref005","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).","volume":"134","author":"X Yang","year":"2016","journal-title":"Circulation"},{"key":"pone.0284877.ref006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cphy.c140055","article-title":"Pathophysiology of Heart Failure","volume":"6","author":"E Tanai","year":"2015","journal-title":"Compr Physiol"},{"key":"pone.0284877.ref007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12933-020-01024-5","article-title":"Reappraisal on pharmacological and mechanical treatments of heart failure","volume":"19","author":"B Liang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0284877.ref008","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tcm.2017.02.005","article-title":"The role of cardiac rehabilitation in patients with heart disease","volume":"27","author":"SR McMahon","year":"2017","journal-title":"Trends Cardiovasc Med"},{"key":"pone.0284877.ref009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tcm.2020.01.007","article-title":"Editorial Commentary: Drug dosing optimization in heart failure: Need of a multidimensional approach (and skilled heart failure specialists)","volume":"31","author":"G. Fragasso","year":"2021","journal-title":"Trends Cardiovasc Med."},{"key":"pone.0284877.ref010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.tcm.2019.08.009","article-title":"Cardiac regenerative therapy: Many paths to repair.","volume":"30","author":"NA Gude","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"pone.0284877.ref011","first-page":"523","article-title":"Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches.","volume":"8","author":"LK Truby","year":"2020","journal-title":"JACC Heart Fail."},{"key":"pone.0284877.ref012","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.21037\/apm-20-697","article-title":"A brief discussion on evidence-based clinical research of traditional Chinese medicine","volume":"10","author":"Y Xin","year":"2021","journal-title":"Ann Palliat Med"},{"key":"pone.0284877.ref013","first-page":"1182","article-title":"Talking about the mechanism of heart decay from huangdi neijing","volume":"33","author":"T Li","year":"2013","journal-title":"Henan Traditional Chinese Medicine"},{"key":"pone.0284877.ref014","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/ha.2009.001123","article-title":"Clinical practice of traditional Chinese medicines for chronic heart failure","volume":"2","author":"S Fu","year":"2010","journal-title":"Heart Asia"},{"key":"pone.0284877.ref015","first-page":"709","article-title":"Modern research progress of Danshen Decoction","volume":"33","author":"L Kong","year":"2019","journal-title":"Chinese Journal of Pharmacology and Toxicology"},{"key":"pone.0284877.ref016","first-page":"27","article-title":"Study on the application of Danshen Yin in cardiovascular disease.","volume":"33","author":"H Chen","year":"2013","journal-title":"Jilin traditional Chinese Medicine."},{"key":"pone.0284877.ref017","first-page":"7578055","article-title":"Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy","volume":"2022","author":"M Liu","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"pone.0284877.ref018","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms","volume":"69","author":"P Hao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"pone.0284877.ref019","doi-asserted-by":"crossref","first-page":"834","DOI":"10.36290\/vnl.2018.114","article-title":"Pathophysiology, causes and epidemiology of chronic heart failure","volume":"64","author":"J \u0160pinar","year":"2018","journal-title":"Vnitr Lek"},{"key":"pone.0284877.ref020","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ehf2.12555","article-title":"Highlights in heart failure","volume":"6","author":"D Tomasoni","year":"2019","journal-title":"ESC Heart Fail"},{"key":"pone.0284877.ref021","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/0929867324666170830100424","article-title":"Biomarkers in Atrial Fibrillation and Heart Failure","volume":"26","author":"E Oikonomou","year":"2019","journal-title":"Curr Med Chem"},{"key":"pone.0284877.ref022","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/ehf2.12680","article-title":"Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure","volume":"7","author":"N Kuster","year":"2020","journal-title":"ESC Heart Fail"},{"key":"pone.0284877.ref023","doi-asserted-by":"crossref","first-page":"e019168","DOI":"10.1161\/JAHA.120.019168","article-title":"Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation","volume":"10","author":"AP Benz","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"pone.0284877.ref024","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/joim.12756","article-title":"Biomarkers for heart failure: small molecules with high clinical relevance","volume":"283","author":"C Magnussen","year":"2018","journal-title":"J Intern Med"},{"key":"pone.0284877.ref025","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"pone.0284877.ref026","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pone.0284877.ref027","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.21037\/apm-21-681","article-title":"Efficacy and safety of integrated traditional Chinese medicine and standard Western medicine for patients with acute coronary syndrome: protocol for a systematic review and meta-analysis.","volume":"10","author":"B Cheng","year":"2021","journal-title":"Ann Palliat Med"},{"key":"pone.0284877.ref028","doi-asserted-by":"crossref","first-page":"e30698","DOI":"10.1097\/MD.0000000000030698","article-title":"Danshen decoction in the treatment of heart failure: A systematic review and meta-analysis protocol of randomized controlled trials","volume":"101","author":"M Liu","year":"2022","journal-title":"Medicine (Baltimore)."},{"key":"pone.0284877.ref029","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"PA Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"pone.0284877.ref030","article-title":"Assessment of the quality of randomized controlled trials in surgery using Jadad score: Where do we stand?","author":"S Mohsina","year":"2022","journal-title":"J Postgrad Med."},{"key":"pone.0284877.ref031","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s11605-012-2106-0","article-title":"A note on the jadad score as an efficient tool for measuring trial quality.","volume":"17","author":"KE Palys","year":"2013","journal-title":"J Gastrointest Surg."},{"key":"pone.0284877.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"pone.0284877.ref033","doi-asserted-by":"crossref","first-page":"e18552","DOI":"10.1097\/MD.0000000000018552","article-title":"Compound Kushen injection plus platinum-based chemotherapy for stage IIIB\/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines","volume":"98","author":"H Chen","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"pone.0284877.ref034","doi-asserted-by":"crossref","first-page":"e17350","DOI":"10.1097\/MD.0000000000017350","article-title":"Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III\/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials","volume":"98","author":"H Chen","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"pone.0284877.ref035","doi-asserted-by":"crossref","first-page":"152787","DOI":"10.1016\/j.phymed.2018.12.010","article-title":"Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III\/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines","volume":"59","author":"X Wang","year":"2019","journal-title":"Phytomedicine"},{"key":"pone.0284877.ref036","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"M Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0284877.ref037","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"pone.0284877.ref038","first-page":"451","article-title":"Grade Guide: III Evidence quality classification","volume":"11","author":"H Balshem","year":"2011","journal-title":"Chinese Journal of evidence based medicine"},{"key":"pone.0284877.ref039","first-page":"437","article-title":"Grade Guide: I Introduction\u2014grade evidence summary table and result summary table","volume":"11","author":"D. Guyatt G","year":"2011","journal-title":"Chinese Journal of evidence based medicine"},{"key":"pone.0284877.ref040","first-page":"446","article-title":"Grade Guide: II Build problems and identify important results","volume":"11","author":"H. Guyatt G","year":"2011","journal-title":"Chinese Journal of evidence based medicine"},{"key":"pone.0284877.ref041","first-page":"456","article-title":"Grade Guide: \u2163 Evidence quality classification\u2014limitations of the study (risk of bias).","volume":"11","author":"H. Guyatt G","year":"2011","journal-title":"Chinese Journal of evidence based medicine"},{"key":"pone.0284877.ref042","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaoncol.2019.5233","article-title":"Clinical Evidence for Association of Acupuncture and Acupressure With Improved Cancer Pain: A Systematic Review and Meta-Analysis","volume":"6","author":"Y He","year":"2020","journal-title":"JAMA Oncol"},{"key":"pone.0284877.ref043","first-page":"555","article-title":"Curative effect of Danshen Decoction on chronic pulmonary heart disease with heart failure and its effect on blood gas index and cardiac function","volume":"50","author":"X Cai","year":"2015","journal-title":"Zhejiang Journal of traditional Chinese Medicine"},{"key":"pone.0284877.ref044","first-page":"64","article-title":"Effect of modified chaiting Danshen Decoction on heart failure of coronary heart disease (syndrome of qi stagnation, blood stasis and water stagnation) and its effect on 24h urine volume and AVP.","volume":"39","author":"Q Guo","year":"2021","journal-title":"Sichuan Traditional Chinese Medicine."},{"key":"pone.0284877.ref045","first-page":"2624","article-title":"Clinical study on the treatment of chronic heart failure with modified Danshen Decoction and Zhenwu Decoction","volume":"17","author":"X Wang","year":"2019","journal-title":"Journal of cardio cerebrovascular diseases with integrated traditional Chinese and Western Medicine"},{"key":"pone.0284877.ref046","first-page":"1702","article-title":"Effect of Shengmai Powder and Danshen Decoction Combined with western medicine on chronic heart failure","volume":"39","author":"G Wei","year":"2018","journal-title":"Shaanxi traditional Chinese Medicine"},{"key":"pone.0284877.ref047","first-page":"2885","article-title":"Clinical observation of Zhenwu decoction combined with Danshen Decoction in treating chronic heart failure of Yang deficiency and blood stasis type","volume":"35","author":"Y Wu","year":"2020","journal-title":"Guangming traditional Chinese Medicine"},{"key":"pone.0284877.ref048","first-page":"46","article-title":"Clinical effect of Danshen Decoction Combined with Xuefu Zhuyu Decoction on chronic heart failure","volume":"11","author":"J Xu","year":"2021","journal-title":"Cardiovascular disease prevention and control knowledge"},{"key":"pone.0284877.ref049","first-page":"18","article-title":"Clinical observation on treatment of angina pectoris of coronary heart disease with ginseng decoction, Gualou xiebanxia Decoction and Danshen Decoction","volume":"34","author":"R. Liu","year":"2018","journal-title":"Journal of practical Chinese Medicine."},{"key":"pone.0284877.ref050","first-page":"83","article-title":"Effects of modified Danshen Decoction Combined with tegrilol on cardiac function, hs CRP, NT proBNP and Fib in patients with coronary heart disease","volume":"32","author":"E Xue","year":"2019","journal-title":"Western Traditional Chinese Medicine"},{"key":"pone.0284877.ref051","first-page":"62","article-title":"Effect of Shengmai Powder and Danshen Yin on diabetes cardiomyopathy and myocardial fibrosis","volume":"54","author":"Y Sheng","year":"2022","journal-title":"New traditional Chinese Medicine"},{"key":"pone.0284877.ref052","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart Failure With Preserved Ejection Fraction In Perspective","volume":"124","author":"MA Pfeffer","year":"2019","journal-title":"Circ Res"},{"key":"pone.0284877.ref053","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"SM Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"pone.0284877.ref054","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-8703(81)90748-1","article-title":"Problems in assessment of new pharmacologic agents for the heart failure patient.","volume":"102","author":"RE Rude","year":"1981","journal-title":"Am Heart J."},{"key":"pone.0284877.ref055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1472-6882-13-132","article-title":"The quest for modernisation of traditional Chinese medicine","volume":"13","author":"Q Xu","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"pone.0284877.ref056","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hfc.2012.09.002","article-title":"End points for comparative effectiveness research in heart failure","volume":"9","author":"LA Allen","year":"2013","journal-title":"Heart Fail Clin"},{"key":"pone.0284877.ref057","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.120.317883","article-title":"Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies","volume":"128","author":"C Wittenbecher","year":"2021","journal-title":"Circ Res"},{"key":"pone.0284877.ref058","doi-asserted-by":"crossref","first-page":"105178","DOI":"10.1016\/j.phrs.2020.105178","article-title":"The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation","volume":"160","author":"R Xie","year":"2020","journal-title":"Pharmacol Res"},{"key":"pone.0284877.ref059","first-page":"2509","article-title":"Protective effect of danshenyin preconditioning on myocardial ischemia-reperfusion injury in rats","volume":"30","author":"Y Ren","year":"2021","journal-title":"Journal of modern integrated traditional Chinese and Western Medicine"},{"key":"pone.0284877.ref060","first-page":"1","article-title":"Study on the mechanism of danshenyin in treating angina pectoris based on network pharmacology","author":"Y Li","journal-title":"World traditional Chinese Medicine."},{"key":"pone.0284877.ref061","first-page":"53","article-title":"Toxicological Experimental Study on Danshen Zhizhu Drink.","volume":"40","author":"M Lu","year":"2009","journal-title":"Jiangxi Traditional Chinese Medicine."},{"key":"pone.0284877.ref062","first-page":"117","article-title":"Advances in pharmacological research and clinical application of Danshen Decoction","volume":"34","author":"S Li","year":"2017","journal-title":"Traditional Chinese Medicine Information"},{"key":"pone.0284877.ref063","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jebm.12389","article-title":"Evidence-based traditional Chinese medicine research: Beijing Declaration","volume":"13","author":"J Zhang","year":"2020","journal-title":"J Evid Based Med"},{"key":"pone.0284877.ref064","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/erm.2018.3","article-title":"What has traditional Chinese medicine delivered for modern medicine?","volume":"20","author":"J Wang","year":"2018","journal-title":"Expert Rev Mol Med"},{"key":"pone.0284877.ref065","first-page":"2893","article-title":"[Future development of evidence based traditional Chinese medicine:flat way to truth and kindness].","volume":"44","author":"Y-Y Wang","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"key":"pone.0284877.ref066","first-page":"1","article-title":"Evidence-based Chinese medicine: theory and practice.","volume":"43","author":"J-H Zhang","year":"2018","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"key":"pone.0284877.ref067","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine","volume":"143","author":"JJV McMurray","year":"2021","journal-title":"Circulation"},{"key":"pone.0284877.ref068","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction","volume":"138","author":"YNV Reddy","year":"2018","journal-title":"Circulation"},{"key":"pone.0284877.ref069","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cjca.2021.01.002","article-title":"Evidence-Based Management of Acute Heart Failure","volume":"37","author":"AK Gupta","year":"2021","journal-title":"Can J Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T17:34:52Z","timestamp":1683308092000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284877"}},"subtitle":[],"editor":[{"given":"Mustafa M.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284877","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]}}}